Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atalo Holdings is a Kentucky-based company specializing in the research, development, and processing of industrial hemp for the healthcare and wellness sectors. The company operates a vertically integrated model that includes crop science, certified seed production, and large-scale extraction of CBD and other cannabinoids. Their primary focus is providing high-quality hemp-derived ingredients for nutraceuticals, functional foods, and topical applications. Atalo's infrastructure includes a dedicated Hemp Processing Center and a Seed Research and Development Center. In 2020, the company's assets were acquired by GenCanna following a financial restructuring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atalo Holdings.